📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The terminal sialic acid of stage-specific embryonic antigen-4 has a crucial role in binding to a cancer-targeting antibody. (2020)

First Author: Soliman C

Attributed to: Improving the functional affinity of human anti-glycan monoclonal antibodies (mabs) for cancer therapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1074/jbc.ra119.011518

PubMed Identifier: 31831622

Publication URI: http://europepmc.org/abstract/MED/31831622

Type: Journal Article/Review

Volume: 295

Parent Publication: The Journal of biological chemistry

Issue: 4

ISSN: 0021-9258